SBIR/STTR Research Award

Validating establishment of functional safety in skin interfacewith deeply porous transcutaneous pylon for direct skeletal attachment of limb prostheses

Award identifier 0ce852599c60aa48d2efced5635158b5c8b27d254f20b74fcb3f0c5ace48226bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,708,048

Program and phase

SBIR · Phase II – Direct to Phase II

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
POLY ORTH INTERNATIONAL
Proposal award date
2021-09-24
Contract end date
2023-08-30
UEI
UKLRCJ4QPJH5
Solicitation number
PA20-260
Topic code
NIAMS

Research abstract

Research efforts of the Poly-Orth International demonstrated feasibility of the novel “Residuum-Integration Prosthetic Technology" to be used in direct skeletal attachment of limb prosthetics. The technology includes a “Skin and Bone Integrated Pylon” (SBIP), which connects the residuum with external limb prosthesis and can be especially beneficial for patients who can not use traditional socket attachment of the prostheses.As histopathology analysis after the study with small and large animals has demonstrated, the SBIP is integrated not only with the residual bone, but also with the residuum’s skin minimizing the risk of infection and secondary trauma. The investigators developed an optimal porous titanium matrix and design of the Skin and Bone Integrated Pylon to maximize the ingrowth of bone and skin cells of the residuum to the SBIP without compromising strength of the implanted device. The technological study on the process of manufacturing of the composite porous structure enforced with a permeable internal frame. Parameters of the SBIP’s specification are protected by the US Patent #8257435.During the proposed translational pre-clinical study, the animal trials will be conducted according to the FDA requirements to ensure smooth translation to the trials in humans. It will include large animals (pigs) and the implantation period up to 22 months.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

8 SBIR/STTR records share this UEI (1999–2025). Reported award amounts total $5,493,447. Reported amounts are not federal obligations.

Phases: Phase II, Phase I, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.